Author

H. Levis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Lawrence· 3 shared R. D. Bowles· 3 shared C. Lewis· 2 shared J. D. Weston· 2 shared A. Lawal· 1 shared B. Austin· 1 shared E. Stockham· 1 shared J. A. Weiss· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

B. Lawrence

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ZNF865 Regulates Senescence and Cell Cycle for Applications to Cell Engineering and Gene Therapy

H. Levis, C. Lewis, E. Stockham, J. D. Weston, A. Lawal, B. Lawrence, S. E. Gullbrand, R. D. Bowles

This study identifies ZNF865 as a regulator of senescence and cell cycle, demonstrating its potential for cell engineering and gene therapy applications.

bioRxiv · Oct 25, 2023Bioengineering

Therapeutic TNF-alpha Delivery After CRISPR Receptor Modulation in the Intervertebral Disc

J. D. Stover, M. A. R. Trone, J. Weston, C. Lewis, H. Levis, M. Philippi, M. Zeidan, B. Lawrence, R. D. Bowles

This study uses CRISPR to modulate TNFR1 in rats, reducing disc degeneration and showing that TNF-alpha injection becomes therapeutic after receptor modulation.

bioRxiv · May 31, 2023Bioengineering

CRISPRi-Driven Osteogenesis in Adipose-Derived Stem Cells for Bone Healing and Tissue Engineering

J. D. Weston, B. Austin, H. Levis, J. Zitnay, J. A. Weiss, B. Lawrence, R. D. Bowles

This study uses CRISPRi to downregulate BMP antagonists in adipose-derived stem cells, promoting osteogenesis without exogenous growth factors and demonstrating multiplex tissue engineering applications.

bioRxiv · Nov 15, 2022Bioengineering